PT - JOURNAL ARTICLE AU - Abalde-Atristain, Leire TI - GALvanizing Alzheimer’s disease therapy to combat the inflamed brain AID - 10.1126/scitranslmed.aax8310 DP - 2019 May 08 TA - Science Translational Medicine PG - eaax8310 VI - 11 IP - 491 4099 - http://stm.sciencemag.org/content/11/491/eaax8310.short 4100 - http://stm.sciencemag.org/content/11/491/eaax8310.full AB - Galectin-3 is elevated in patients with Alzheimer’s disease (AD), and its deletion reduces neuroinflammation and β-amyloid burden in a mouse model of AD.